There are five gynecological cancers: ovarian, cervical, womb, vaginal and vulva. Awareness level of these cancers are very low especially in Africa.
According to GLOBOCAN, out of 36 globally recognized cancers, the gynecological cancers: cervical, uterine and ovarian are among the ten most common. Only in 2018, there were 1,309,165.00 new cases of gynecological cancers, constituting 7.20% of the global cancer cases. Death toll from the gynecological cancers was 609,377.00 (5.50%). ‘Cervical cancer’ is the second leading cause of cancer deaths in women globally. Most cases of the cervical cancer occur in the developing world. Africa has the highest mortality rates and incidence frequently equating with mortality in the absence of healthcare facilities to deal with the gynecological cancers.
Global increase in mortality rate due to cervical cancer alone outnumber death from malaria, tuberculosis and HIV/AIDS all put together. Yet, the number of new cancer cases have been projected to rise up to 1.28 million by 2030 with 970,000 cancer deaths. Since the recognition of ‘Acquired Immunodeficiency Syndrome’ (AIDS) in 1981, continuous increased burden of cervical cancer is being identified among Human Immunodeficiency Virus (HIV)-positive women. Oftentimes the combined burden of cervical cancer and HIV leads to osteoporosis/bone fracture. The adverse effects of these gynecological cancers on women include; feeling of isolation, depression, distress, anxiety, sexual dysfunction, body image issues and infertility.
Aware of the fact that these cancers can be prevented, Foundation for Women’s Health Promotion and Welfare Initiatives inspires organized campaign for research and other activities aiming at cost effective anti-cancer pharmaceutical products, using indigenous medicinal plants to fight gynecological cancers and their correlated diseases. Our Foundation is encouraged by the commoving condition of millions of African women afflicted and threatened to death by these preventable type of cancers, and by our awareness of the fact that fatal incidence of the Gynecological Cancers could be mitigated if attention is paid on prevention and pharmaceutical research support.
ABOUT THE FOUNDER
Who cannot imagine the trauma of one losing a young mother, a young sister, a relative or a friend just for mere preventable malignancies? Who cannot imagine the trauma and stress in families with a dying mum, sister or relative? From lived experience, I have come to learn that a woman’s lack of good health also has a negative impact on the health and well being of her whole family. The drastic conditions gynecological cancers place on Sub-Sahara African women has set my passion and career goal to getting life-changing anti-cancer solutions into the hands of millions of people experiencing severe trauma and stress.
I am a biomedical scientist, specialized in Cellular and Molecular bases of Pathology Differentiation in Cancer and Degenerative Diseases. Embarking on research with African medicinal plants, and campaigning for early detection, community education/information outreach to combat cancer malignancies and their correlated diseases such as osteoporosis/bone diseases is a mission I have undertaken as a life call.